Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist

A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International archives of occupational and environmental health 1985, Vol.56 (1), p.41-47
Hauptverfasser: Lange Andersen, K, Piatkowski, W, Green, K A, Ottmann, W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 1
container_start_page 41
container_title International archives of occupational and environmental health
container_volume 56
creator Lange Andersen, K
Piatkowski, W
Green, K A
Ottmann, W
description A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by the manufactures were used. Atenolol (100 mg) given once a day resulted in a marked hypotensive effect at rest as well as during exercise, the compliance was satisfactory, and the hemodynamic changes were not reflected in unfavourable side effects during muscular exercise or in the subjects own personal assessment of fatigue during the exercise tests which ranged in energy expenditure from about three to six times the resting level. However, unfavourable, modest side effects occurred in two subjects during atenolol medication to the extent that they wanted to terminate the study. Nifedipine therapy with doses of 10 mg, three times a day, resulted in a modest, but statistically insignificant reduction in arterial blood pressure, which contrasts with previous published results. It is suggested that the modest effect is caused or related to the poor compliance and a daily dose that was quantitatively too small. No unfavourable side effects were seen during muscular efforts when the subjects were on nifedipine medication.
doi_str_mv 10.1007/BF00380699
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00380699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2863220</sourcerecordid><originalsourceid>FETCH-LOGICAL-c156t-baf727bfec5a76bd63e7864b1bbb5c9de7f9dac8293ecd99d3b1aa3e18d0d7c23</originalsourceid><addsrcrecordid>eNpFkE1LAzEURYMotVY37oWshanJpJ3MLLVYFQpuFJflJXlTozPJkGTQ_h7_qP1CV_ddOLwLh5BLzsacMXlzN2dMlKyoqiMy5BORZzyfFMdkyMSEZYwLfkrOYvxgjMtCigEZ5GUh8pwNyc-bD5_WrSgo29i0puAMxW8M2kakyTcYwGmkpg9bKgWE1KJL1NcUaGsbQ9_XHYaELlrvxvRpTGe-7SDY6B1VmL4Q3QbdXJCBCeh8FlBjl3ygqvF6t25Cv9pNA9XQaNu3m5Zg5Z2N6Zyc1NBEvDjkiLzO719mj9ni-eFpdrvINJ8WKVNQy1yqGvUUZKFMIVCWxURxpdRUVwZlXRnQZV4J1KaqjFAcQCAvDTNS52JErvd_dfAxBqyXXbAthPWSs-VW9PJf9Aa-2sNdr1o0f-jBrPgFo0J9Gw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Lange Andersen, K ; Piatkowski, W ; Green, K A ; Ottmann, W</creator><creatorcontrib>Lange Andersen, K ; Piatkowski, W ; Green, K A ; Ottmann, W</creatorcontrib><description>A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by the manufactures were used. Atenolol (100 mg) given once a day resulted in a marked hypotensive effect at rest as well as during exercise, the compliance was satisfactory, and the hemodynamic changes were not reflected in unfavourable side effects during muscular exercise or in the subjects own personal assessment of fatigue during the exercise tests which ranged in energy expenditure from about three to six times the resting level. However, unfavourable, modest side effects occurred in two subjects during atenolol medication to the extent that they wanted to terminate the study. Nifedipine therapy with doses of 10 mg, three times a day, resulted in a modest, but statistically insignificant reduction in arterial blood pressure, which contrasts with previous published results. It is suggested that the modest effect is caused or related to the poor compliance and a daily dose that was quantitatively too small. No unfavourable side effects were seen during muscular efforts when the subjects were on nifedipine medication.</description><identifier>ISSN: 0340-0131</identifier><identifier>EISSN: 1432-1246</identifier><identifier>DOI: 10.1007/BF00380699</identifier><identifier>PMID: 2863220</identifier><language>eng</language><publisher>Germany</publisher><subject>Adrenergic beta-Antagonists - adverse effects ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; Atenolol - adverse effects ; Atenolol - therapeutic use ; Blood Pressure - drug effects ; Calcium Channel Blockers - adverse effects ; Calcium Channel Blockers - therapeutic use ; Clinical Trials as Topic ; Disability Evaluation ; Female ; Heart Rate - drug effects ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Male ; Middle Aged ; Nifedipine - adverse effects ; Nifedipine - therapeutic use ; Physical Endurance ; Physical Exertion ; Random Allocation ; Work Capacity Evaluation</subject><ispartof>International archives of occupational and environmental health, 1985, Vol.56 (1), p.41-47</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c156t-baf727bfec5a76bd63e7864b1bbb5c9de7f9dac8293ecd99d3b1aa3e18d0d7c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2863220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lange Andersen, K</creatorcontrib><creatorcontrib>Piatkowski, W</creatorcontrib><creatorcontrib>Green, K A</creatorcontrib><creatorcontrib>Ottmann, W</creatorcontrib><title>Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist</title><title>International archives of occupational and environmental health</title><addtitle>Int Arch Occup Environ Health</addtitle><description>A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by the manufactures were used. Atenolol (100 mg) given once a day resulted in a marked hypotensive effect at rest as well as during exercise, the compliance was satisfactory, and the hemodynamic changes were not reflected in unfavourable side effects during muscular exercise or in the subjects own personal assessment of fatigue during the exercise tests which ranged in energy expenditure from about three to six times the resting level. However, unfavourable, modest side effects occurred in two subjects during atenolol medication to the extent that they wanted to terminate the study. Nifedipine therapy with doses of 10 mg, three times a day, resulted in a modest, but statistically insignificant reduction in arterial blood pressure, which contrasts with previous published results. It is suggested that the modest effect is caused or related to the poor compliance and a daily dose that was quantitatively too small. No unfavourable side effects were seen during muscular efforts when the subjects were on nifedipine medication.</description><subject>Adrenergic beta-Antagonists - adverse effects</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Atenolol - adverse effects</subject><subject>Atenolol - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>Calcium Channel Blockers - adverse effects</subject><subject>Calcium Channel Blockers - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nifedipine - adverse effects</subject><subject>Nifedipine - therapeutic use</subject><subject>Physical Endurance</subject><subject>Physical Exertion</subject><subject>Random Allocation</subject><subject>Work Capacity Evaluation</subject><issn>0340-0131</issn><issn>1432-1246</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LAzEURYMotVY37oWshanJpJ3MLLVYFQpuFJflJXlTozPJkGTQ_h7_qP1CV_ddOLwLh5BLzsacMXlzN2dMlKyoqiMy5BORZzyfFMdkyMSEZYwLfkrOYvxgjMtCigEZ5GUh8pwNyc-bD5_WrSgo29i0puAMxW8M2kakyTcYwGmkpg9bKgWE1KJL1NcUaGsbQ9_XHYaELlrvxvRpTGe-7SDY6B1VmL4Q3QbdXJCBCeh8FlBjl3ygqvF6t25Cv9pNA9XQaNu3m5Zg5Z2N6Zyc1NBEvDjkiLzO719mj9ni-eFpdrvINJ8WKVNQy1yqGvUUZKFMIVCWxURxpdRUVwZlXRnQZV4J1KaqjFAcQCAvDTNS52JErvd_dfAxBqyXXbAthPWSs-VW9PJf9Aa-2sNdr1o0f-jBrPgFo0J9Gw</recordid><startdate>1985</startdate><enddate>1985</enddate><creator>Lange Andersen, K</creator><creator>Piatkowski, W</creator><creator>Green, K A</creator><creator>Ottmann, W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1985</creationdate><title>Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist</title><author>Lange Andersen, K ; Piatkowski, W ; Green, K A ; Ottmann, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c156t-baf727bfec5a76bd63e7864b1bbb5c9de7f9dac8293ecd99d3b1aa3e18d0d7c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Adrenergic beta-Antagonists - adverse effects</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Atenolol - adverse effects</topic><topic>Atenolol - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>Calcium Channel Blockers - adverse effects</topic><topic>Calcium Channel Blockers - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nifedipine - adverse effects</topic><topic>Nifedipine - therapeutic use</topic><topic>Physical Endurance</topic><topic>Physical Exertion</topic><topic>Random Allocation</topic><topic>Work Capacity Evaluation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lange Andersen, K</creatorcontrib><creatorcontrib>Piatkowski, W</creatorcontrib><creatorcontrib>Green, K A</creatorcontrib><creatorcontrib>Ottmann, W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>International archives of occupational and environmental health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lange Andersen, K</au><au>Piatkowski, W</au><au>Green, K A</au><au>Ottmann, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist</atitle><jtitle>International archives of occupational and environmental health</jtitle><addtitle>Int Arch Occup Environ Health</addtitle><date>1985</date><risdate>1985</risdate><volume>56</volume><issue>1</issue><spage>41</spage><epage>47</epage><pages>41-47</pages><issn>0340-0131</issn><eissn>1432-1246</eissn><abstract>A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by the manufactures were used. Atenolol (100 mg) given once a day resulted in a marked hypotensive effect at rest as well as during exercise, the compliance was satisfactory, and the hemodynamic changes were not reflected in unfavourable side effects during muscular exercise or in the subjects own personal assessment of fatigue during the exercise tests which ranged in energy expenditure from about three to six times the resting level. However, unfavourable, modest side effects occurred in two subjects during atenolol medication to the extent that they wanted to terminate the study. Nifedipine therapy with doses of 10 mg, three times a day, resulted in a modest, but statistically insignificant reduction in arterial blood pressure, which contrasts with previous published results. It is suggested that the modest effect is caused or related to the poor compliance and a daily dose that was quantitatively too small. No unfavourable side effects were seen during muscular efforts when the subjects were on nifedipine medication.</abstract><cop>Germany</cop><pmid>2863220</pmid><doi>10.1007/BF00380699</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-0131
ispartof International archives of occupational and environmental health, 1985, Vol.56 (1), p.41-47
issn 0340-0131
1432-1246
language eng
recordid cdi_crossref_primary_10_1007_BF00380699
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - therapeutic use
Adult
Atenolol - adverse effects
Atenolol - therapeutic use
Blood Pressure - drug effects
Calcium Channel Blockers - adverse effects
Calcium Channel Blockers - therapeutic use
Clinical Trials as Topic
Disability Evaluation
Female
Heart Rate - drug effects
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Male
Middle Aged
Nifedipine - adverse effects
Nifedipine - therapeutic use
Physical Endurance
Physical Exertion
Random Allocation
Work Capacity Evaluation
title Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Working%20ability%20and%20exercise%20tolerance%20during%20treatment%20of%20a%20mild%20hypertension.%20I.%20Comparison%20between%20a%20beta-adreno-receptor%20blocking%20drug%20and%20a%20calcium%20antagonist&rft.jtitle=International%20archives%20of%20occupational%20and%20environmental%20health&rft.au=Lange%20Andersen,%20K&rft.date=1985&rft.volume=56&rft.issue=1&rft.spage=41&rft.epage=47&rft.pages=41-47&rft.issn=0340-0131&rft.eissn=1432-1246&rft_id=info:doi/10.1007/BF00380699&rft_dat=%3Cpubmed_cross%3E2863220%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2863220&rfr_iscdi=true